Durham, NC, United States of America

Frank Ulrich Schmitz

This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline LLC. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Ulrich Schmitz. Retrieved from https://idiyas.com/inventor/frank-ulrich-schmitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Ulrich Schmitz: Innovator in Anti-Viral Compounds

Introduction

Frank Ulrich Schmitz is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral compounds. His work focuses on addressing infections caused by viruses in the Flaviviridae family.

Latest Patents

Frank Ulrich Schmitz holds 1 patent for his invention titled "Anti-viral compounds, compositions, and methods of use." This patent discloses various compounds, stereoisomers, tautomers, and pharmaceutically acceptable salts. It details their preparation, use, and compositions for treating infections mediated by specific viruses.

Career Highlights

Frank is currently employed at GlaxoSmithKline LLC, where he continues to innovate in the pharmaceutical sector. His expertise in anti-viral research has positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Throughout his career, Frank has collaborated with talented professionals, including Roopa Rai and Christopher Roberts. These partnerships have enhanced his research and contributed to the advancement of anti-viral therapies.

Conclusion

Frank Ulrich Schmitz exemplifies the spirit of innovation in the pharmaceutical industry. His work on anti-viral compounds showcases the importance of research in combating viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…